Figure S2 from <i>NF1</i> Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in <i>NF1</i>-Mutant Melanoma
<p>High EGFR expression correlates with worse outcomes in NF1 mutant but not BRAF or NRAS mutant melanoma</p>
Authors
- Irineu Illa-Bochaca (ORCID: https://orcid.org/0000-0002-8039-565X)
- Kelly V. Ruggles (ORCID: https://orcid.org/0000-0002-0152-0863)
- Markus Schöber (ORCID: https://orcid.org/0000-0002-9122-2121)
- Milad Ibrahim (ORCID: https://orcid.org/0000-0001-8841-7393)
- Eleazar Vega‐Saenz de Miera (ORCID: https://orcid.org/0000-0001-8443-1286)
- George Jour (ORCID: https://orcid.org/0000-0001-8916-8966)
- Iman Osman (ORCID: https://orcid.org/0000-0002-1472-1971)
- Joseph Fracasso
Publication Details
- Published
- 2025-09-02
- DOI
- https://doi.org/10.1158/0008-5472.30029888
- Primary Topic
- Melanoma and MAPK Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00